MYELOPROLIFERATIVE NEOPLASMS TREATMENT MARKET ANALYSIS

Myeloproliferative Neoplasms Treatment Market, By Disease Type (Essential Thrombocythemia (ET), Myelofibrosis (MF), Polycythemia Vera (PV)), By Drug Class (Tyrosine Kinase Inhibitors, Janus kinase inhibitors (JAKi), Antimetabolites, Others (alkylating agents, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI930
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Myeloproliferative Neoplasms Treatment Market - Key Players

Major players operating in the global myeloproliferative neoplasms treatment market include Novartis AG, PharmaEssentia Corporation, Bristol Myers Squibb, Pfizer, Inc., Takeda Pharmaceutical Company Limited, Incyte, Johnson & Johnson, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche AG, Gamida Cell, Sierra Oncology, Inc, CTI BioPharma Corp, Imago BioSciences, AbbVie Inc, and Constellation Pharmaceuticals.

Myeloproliferative Neoplasms Treatment Market Report Snapshots